I am a
Home I AM A Search Login

Papers of the Week

Papers: 8 Jun 2024 - 14 Jun 2024

2024 Jun 13

Expert Rev Neurother


An update on pharmacotherapy for trigeminal neuralgia.


Pergolizzi JV, LeQuang JA, El-Tallawy SN, Wagner M, Ahmed RS, Varrassi G


Trigeminal neuralgia is a rare condition that can be effectively treated by carbamazepine or oxcarbazepine but these older drugs are associated with dose-dependent and potentially treatment-limiting adverse effects. Third-generation anticonvulsants, new calcitonin gene-related peptide blockers for migraine, and older drugs such as ketamine and cannabinoids may be promising adjuvants or monotherapeutic options.